Expanding Opportunities in the Medical Wearables Market
The medical wearables market
is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in
2020, at a CAGR of 21.4% during the forecast period. The growing demand
for advanced clinical-grade wearables to streamline complex operational
procedures among healthcare organizations has led to a number of product
launches & enhancements in recent years. Companies focus on
launching innovative solutions to gain a competitive edge and exploit
market growth opportunities offered by advanced and next-generation
wearables.
The prominent players in this market are Medtronic
plc. (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON
Corporation (Japan), Biotelemetry Inc.(US), Apple, Inc. (US ), Dexcom
Inc. (US), Abbott Laboratories(US), Masimo Corporation(US), GE
Healthcare (US), Bio-Beat Technologies (Israel), iRhythm Technologies,
Inc.(US), VitalConnect (US), Minttihealth (US), Preventice Solutions,
Inc. (US), Contec Medical Systems Co.Ltd(China), Biotricity Inc.(US),
Verily Life Sciences. (US), Cyrcardia Asia Limited (Hong Kong ), ten3T
healthcare (India), VivaLnk, Inc.(US).
To know about the assumptions considered for the study download the pdf brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52426876
Koninklijke Philips N.V. (Netherlands)
Koninklijke
Philips dominated the clinical-grade wearables market in 2019. This
share can be attributed to the company’s wide offerings in the wearables
market and its global presence. Philips has mainly adopted product
launches as its key growth strategy to increase its share in the market.
For instance, in 2018, Philips launched the fetal monitor - Avalon
Beltless Solution. This patch is placed on the expectant mothers belly
to capture critical parameters by measuring fetal and maternal heart
rate and uterine activity via ECG and EMG signals.
Omron Corporation (Japan)
Omron
Corporation is the second-largest player in the clinical-grade
wearables market. The company derives the majority of its revenue from
its operations in North America. However, the firm intends to expand its
business in the international market, mainly through partnerships and
product launches. For instance, in February 2019, Omron collaborated
with PhysIQ (US) to integrate Omron’s innovative FDA-cleared device,
HeartGuide, the first wearable blood pressure monitor, into the
pinpointIQ (physIQ) platform to monitor at-risk patients in outpatient
settings. Similarly, in 2018, Omron launched its first wearables blood
pressure monitor watch HeartGuide. The company also invests in R&D
to expand its capabilities in the field of clinical-grade wearables.
Related Links
https://www.marketsandmarkets.com/Market-Reports/medical-wearables-market-52426876.html
https://www.marketsandmarkets.com/ResearchInsight/medical-wearables-market.asp
https://www.marketsandmarkets.com/PressReleases/medical-wearables.asp
Comments
Post a Comment